Brief: Perrigo Receives Binding Offer To Divest Its HRA Pharma Rare Diseases Business For Up To €275 Mln

Perrigo

25/04/2024 11:07

April 25 (Reuters) - Perrigo Company PLC  PRGO.N :
    * PERRIGO RECEIVES BINDING OFFER TO DIVEST ITS HRA PHARMA
RARE
DISEASES BUSINESS FOR UP TO €275 MILLION
    * PERRIGO COMPANY PLC: EXPECTED NET PROCEEDS TO BE
REDEPLOYED FOR
DEBT REPAYMENT
    * PERRIGO COMPANY PLC - EXPECTED IMPACT FROM THIS PROPOSED
DIVESTMENT WAS INCLUDED IN COMPANY'S PREVIOUSLY ISSUED 2024
OUTLOOK
    * PERRIGO COMPANY PLC: EXPECTED IMPACT FROM THIS PROPOSED
DIVESTMENT WAS INCLUDED IN COMPANY'S PREVIOUSLY ISSUED 2024
OUTLOOK
    * PERRIGO COMPANY PLC - TOTAL CONSIDERATION WOULD BE
ACCRETIVE TO
PERRIGO'S CURRENT ENTERPRISE VALUE-TO-EBITDA MULTIPLE

Source text for Eikon:  ID:nPn79FNsva 
Further company coverage:  PRGO.N 

 ((Reuters.Briefs@thomsonreuters.com;))